Vivesto AB (OTCPK:OASMY)
$ 0.0499 0 (0%) Market Cap: 8.95 Mil Enterprise Value: 4.42 Mil PE Ratio: 0 PB Ratio: 0.79 GF Score: 38/100

Q2 2021 Oasmia Pharmaceutical AB Earnings Call Transcript

Aug 19, 2021 / 08:00AM GMT
Release Date Price: $0.92255
Operator

Welcome to the Oasmia Pharmaceutical Audiocast Teleconference Q2 2021. With us today, we have CEO, Francois R. Martelet; and CFO, Fredrik Jarrsten.

(Operator Instructions) I will now hand over to Francois. Please go ahead.

Francois R. Martelet;publ;CEO
Oasmia Pharmaceutical AB

()-

Thank you very much, and good morning, everyone. It's a pleasure to provide you with an update on our Q2 and interim results, together with our CFO, Fredrik Jarrsten.

Fredrik Jarrsten;publ;CFO
Oasmia Pharmaceutical AB

()-

Good morning.

Francois R. Martelet;publ;CEO
Oasmia Pharmaceutical AB

()-

So Slide 2 is forward-looking statement, as I would not ask to read, obviously. Slide 3 is to the speaker slide. So now Slide 4.

So this quarter was essentially a quarter of transition and build, as we continue to a greater level of internal capabilities, continue to make the best decisions

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot